• Other
  • Exited

ARYx Therapeutics, Inc. used its RetroMetabolic Drug Design technology to design molecules that retain the efficacy of original and well-established drugs but which are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these original compounds.